TET Enzymes as Oxygen-Dependent Tumor Suppressors: Exciting New Avenues for Cancer Management

References

• Tahiliani M , KohKP , ShenYet al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 . Science324 ( 5929 ), 930 – 935 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• He YF , LiBZ , LiZet al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA . Science333 ( 6047 ), 1303 – 1307 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Scourzic L , MoulyE , BernardOA . TET proteins and the control of cytosine demethylation in cancer . Genome Med.7 ( 1 ), 9 ( 2015 ).
   PubMedGoogle Scholar
• Quivoron C , CouronnéL , Della ValleVet al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis . Cancer Cell20 ( 1 ), 25 – 38 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• De Keersmaecker K , AtakZK , LiNet al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia . Nat. Genet.45 ( 2 ), 186 – 190 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kandoth C , McLellanMD , VandinFet al. Mutational landscape and significance across 12 major cancer types . Nature502 ( 7471 ), 333 – 339 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cimmino L , DawlatyMM , Ndiaye-LobryDet al. TET1 is a tumor suppressor of hematopoietic malignancy . Nat. Immunol.16 ( 6 ), 653 – 662 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Spans L , Van Den BroeckT , SmeetsEet al. Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1 . Oncotarget7 ( 17 ), 24326 – 24338 ( 2016 ).
   PubMedGoogle Scholar
• Thienpont B , SteinbacherJ , ZhaoHet al. Tumor hypoxia causes DNA hypermethylation by reducing TET activity . Nature doi:10.1038/nature19081 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Guo X , LongJ , ZengCet al. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk . Cancer Epidemiol. Biomarkers Prev.24 ( 11 ), 1680 – 1691 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kim YH , PierscianekD , MittelbronnMet al. TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations . J. Clin. Pathol.64 ( 10 ), 850 – 852 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Song SJ , PolisenoL , SongMSet al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling . Cell154 ( 2 ), 311 – 324 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yang H , LiuY , BaiFet al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation . Oncogene32 ( 5 ), 663 – 669 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Huang Y , RaoA . Connections between TET proteins and aberrant DNA modification in cancer . Trends Genet.30 ( 10 ), 464 – 474 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Xiao M , YangH , XuWet al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors . Genes Dev.26 ( 12 ), 1326 – 1338 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Figueroa ME , Abdel-WahabO , LuCet al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation . Cancer Cell18 ( 6 ), 553 – 567 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sciacovelli M , GonçalvesE , JohnsonTIet al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition . Nature doi:10.1038/nature19353 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Vaupel P , HockelM , MayerA . Detection and characterization of tumor hypoxia using pO2 histography . Antioxid. Redox Signal.9 ( 8 ), 1221 – 1235 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Wauters E , JanssensW , VansteenkisteJet al. DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature . Thorax70 ( 12 ), 1113 – 1122 ( 2015 ).
   PubMedGoogle Scholar
• Keith B , JohnsonRS , SimonMC . HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumor growth and progression . Nat. Rev. Cancer12 ( 1 ), 9 – 22 ( 2012 ).
   Web of Science ®Google Scholar
• Hu L , LuJ , ChengJet al. Structural insight into substrate preference for TET-mediated oxidation . Nature527 ( 7576 ), 118 – 122 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Blaschke K , EbataKT , KarimiMMet al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells . Nature500 ( 7461 ), 222 – 226 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Li J , LindstromLS , FooJNet al. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy . Nat. Commun.5 , 4051 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bachman M , Uribe-LewisS , YangX , WilliamsM , MurrellA , BalasubramanianS . 5-Hydroxymethylcytosine is a predominantly stable DNA modification . Nat. Chem.6 ( 12 ), 1049 – 1055 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , IssaJP , BaylinS . Targeting the cancer epigenome for therapy . Nat. Rev. Genet.17 ( 10 ), 630 – 641 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Stewart DJ , IssaJ-P , KurzrockRet al. Decitabine effect on tumor global DNA methylation and other parameters in a Phase I trial in refractory solid tumors and lymphomas . Clin. Cancer Res.15 ( 11 ), 3881 – 3888 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Stein EM . IDH2 inhibition in AML: finally progress?Best Pract. Res. Clin. Haematol.28 ( 2 ), 112 – 115 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Heist RS , DudaDG , SahaniDVet al. Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer . Proc. Natl. Acad. Sci. USA112 ( 5 ), 1547 – 1552 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mayland CR , BennettMI , AllanK . Vitamin C deficiency in cancer patients . Pall. Med.19 ( 1 ), 17 – 20 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Creagan ET , MoertelCG , O’FallonJRet al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer . N. Engl. J. Med.301 ( 13 ), 687 – 690 ( 1979 ).
   PubMed Web of Science ®Google Scholar
• Peiris-Pages M , Martinez-OutschoornUE , SotgiaF , LisantiMP . Metastasis and oxidative stress: are antioxidants a metabolic driver of progression?Cell Metab.22 ( 6 ), 956 – 958 ( 2015 ).
   PubMed Web of Science ®Google Scholar